Page 172 - 80_01

Basilio
Colligris,
Jesús
Pintor

Table
1.-­-
Drugs
and
properties.

Drug
Company
Properties
Phase

AL-­-2178/Rimexolone
Alcon/Novartis
Anti-­-inflammatory
Phase
III

LX214/Voclosporin
Isotechnika
and
Lux
Anti-­-inflammatory
Phase
I

Biosciences

Tofacitinib
Pfizer
Inc.
Anti-­-inflammatory
Phase
II

Nutrilarm®-­-Omega-­-3
and
Omega
ThéaLaboratoire
Anti-­-inflammatory
Phase
II

6
fatty
acids

Omega-­-3-­-acid
ethyl
esters
Lovaza,
Anti-­-inflammatory
Phase
I

GlaxoSmithKline

Secukinumab
and
Canakinumab
Novartis
Anti-­-inflammatory
Phase
II

Pharmaceuticals

MIM-­-D3
Mimetogen
Mucin
secretagogue
Phase
II

Pharmaceuticals

Difluprednate-­-Durezol
Alcon/Novartis
Anti-­-inflammatory
Phase
II

Cis-­-urocanic
acid

LaurantisPharma
Anti-­-inflammatory
Phase
I

Thymosin
Beta
4
RegeneRx
Anti-­-inflammatory
Phase
II

Biopharmaceuticals,

Inc.
Anti-­-inflammatory
Phase
II

Belimumab
University
of
Udine
Anti-­-inflammatory
Phase
III

Rituximab
IDEC

Pharmaceuticals
Anti-­-inflammatory
Phase
II

Lotemax
Bausch
&
Lomb
Inc.
Phase
II

Ecabet
sodium

Bausch
&
Lomb
Inc.
Mucin
secretagogue
Phase
II

BOL-­-303242-­-X
(mapracorat)
Bausch
&
Lomb
Inc.
Phase
II

AL43546
Alcon/Novartis
Anti-­-inflammatory
Phase
II

Sirolimus-­-Rapamycin
Santen

Pharmaceutical
Artificial
tears
Phase
II

ISV-­-101

InSite
Vision
Anti-­-inflammatory
Phase
II

and
Phase
II

ESBA-­-105
Alcon
and
ESBATech
immunosuppressive

Dong-­-A
Phase
II

DA-­-6034
Pharmaceutical
Co.
Anti-­-inflammatory

Resolvyx
Phase
I

Pharmaceuticals
Anti-­-inflammatory

RX-­-10045
Alcon/Novartis
Mucin
secretagogue
Phase
II

Sylentis
Anti-­-inflammatory
Phase
II

Tobradex
(tobramycin/
Rigel
Anti-­-inflammatory
Phase
I

dexamethasone)
Pharmaceuticals

Eleven

Lowers
dry-­-eye

SYL1001
Biotherapeutics
related
pain

R932348
Anti-­-inflammatory

EBI-­-005
Anti-­-inflammatory

168